"Isoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies from an individual that react with ISOANTIGENS of another individual of the same species.
| Descriptor ID |
D007518
|
| MeSH Number(s) |
D12.776.124.486.485.114.664 D12.776.124.790.651.114.664 D12.776.377.715.548.114.664
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Isoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Isoantibodies".
This graph shows the total number of publications written about "Isoantibodies" by people in this website by year, and whether "Isoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 2 | 2 |
| 2001 | 1 | 2 | 3 |
| 2002 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 2 | 4 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 3 | 1 | 4 |
| 2011 | 1 | 2 | 3 |
| 2013 | 2 | 2 | 4 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 3 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 0 | 2 | 2 |
| 2018 | 4 | 0 | 4 |
| 2019 | 5 | 0 | 5 |
| 2020 | 4 | 4 | 8 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 1 | 2 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Isoantibodies" by people in Profiles.
-
Identification of a novel biomarker of antibody-mediated rejection in heart transplantation: synergistic effect of anti-nuclear antibodies and de novo donor-specific IgG HLA antibodies. Front Immunol. 2025; 16:1550779.
-
Cutting to the chase: Pruning alloreactive T cells. Immunity. 2025 Feb 11; 58(2):270-272.
-
Alloimmunization in Pregnancy: Implications for the Fetus and Neonate. Neoreviews. 2024 Nov 01; 25(11):e742-e746.
-
Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody. Transfusion. 2024 Jun; 64(6):1161-1166.
-
Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies. J Heart Lung Transplant. 2024 04; 43(4):663-672.
-
Spherotech-EDTA combined serum treatment reduces background more effectively as compared to One Lambda Adsorb Out™ and LIFECODES Serum Cleaner in Luminex-based solid-phase immunoassays for HLA antibody detection. HLA. 2023 08; 102(2):147-156.
-
Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report. Am J Transplant. 2023 01; 23(1):133-149.
-
From bench to bedside: reversing established antibody responses and desensitization. Curr Opin Organ Transplant. 2022 10 01; 27(5):376-384.
-
Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. Transfusion. 2022 07; 62(7):1446-1451.
-
Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy. Transfusion. 2022 04; 62(4):916-918.